References
Bi S, Yao X, Huang C, et al. Antagonistic effect between tigecycline and meropenem: successful management of KPC-producing Klebsiella pneumoniae infection. Infection. 2019;47:497–500.
Tuon FF, Graf ME, Merlini A, et al. Risk factors for mortality in patients with ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae. Braz J Infect Dis. 2017;21:1–6
Toledo PV, Aranha Junior AA, Arend LN, Ribeiro V, Zavascki AP, Tuon FF. Activity of antimicrobial combinations against KPC-2-producing Klebsiella pneumoniae in a rat model and time-kill assay. Antimicrob Agents Chemother. 2015;59:4301–4.
Toledo PV, Tuon FF, Arend L, Aranha Junior AA. Efficacy of tigecycline, polymyxin, gentamicin, meropenem and associations in experimental Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae non-lethal sepsis. Braz J Infect Dis. 2014;18:574–5.
Stein C, Makarewicz O, Bohnert JA, et al. Three dimensional checkerboard synergy analysis of colistin, meropenem, tigecycline against multidrug-resistant clinical Klebsiella pneumonia isolates. PLoS One. 2015;10:e0126479.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Felipe Tuon has received research grants from Pfizer and MSD in the last year. Felipe Tuon conducts research for CNPQ.
Rights and permissions
About this article
Cite this article
Arend, L., Telles, J.P. & Tuon, F.F. Antagonistic effect between tigecycline and meropenem: from bed to bench to bed. Infection 48, 141–142 (2020). https://doi.org/10.1007/s15010-019-01353-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-019-01353-y